Gut Microbiota

Although the bacterial community resident in the human gut has evolved over millions of years, research into the functions of those bacteria has developed exponentially only in the last decade or so.1,2  Early life has been identified as a significant period for the establishment of the gut microbiota with a number of key factors at this time influencing the nature of that development.1-3  Disturbances in the gut microbiota, sometimes referred to as dysbiosis, has been linked to numerous diseases and conditions in infancy and childhood including allergy, obesity, diabetes, coeliac disease and asthma.2

One significant early life event that has been repeatedly linked to differences in the infant gut microbiome is the mode of delivery, that is, Caesarean section versus vaginal delivery.4-6  Such differences may be important as a recent publication from a longitudinal study in 150 countries revealed that the number of births by Caesarean section had increased from 6.7% in 1990 to 19.1% in 2014.7

Intestinal bacterial colonisation with Lactobacillus, Bifidobacterium and Bacteroides has been reported to be delayed in children born via Caesarean section when compared to infants born vaginally.8 A delay in Bacteroidetes colonisation has been reported up to 1 year after Caesarean section delivery.9

Another important factor is antibiotic use in early life.  Whilst, of course, antibiotics are a treatment option in infectious diseases, their use in early life can cause dysbiosis affecting both beneficial and harmful bacteria.10 The effect of antibiotics on the microbiota is influenced by many factors including the age at the time of treatment as well as the duration of use, frequency and dosage.11 Antibiotic use has been shown to reduce the abundance of beneficial Bifidobacterium as well increasing the ratio of Firmicutes to Bacteriodetes12-13 which in some, but not all studies, has been associated with obesity.14-16

One of the most powerful factors that impacts upon the gut microbiota is breastfeeding.17,18  It has been reported that the breastfed infant has significant quantities of Bifidobacterium longum that are able to metabolise human milk oligosaccharides in the colon.2  The short-chain fatty acids produced by this metabolism have been associated with gut epithelial integrity, differentiation of T cells and anti-inflammatory responses.19

In summary, the gut microbiota has a significant role in the infants developing immune system which, in turn, can influence short term and long term health and disease risk.2  It has been suggested that the next stage of development in this area will be targeted microbial therapy although before that can occur more research and information is required relating to the complex gut microbiota.2

References

  1. Goulet O et al, Paediatricians play a key role in preventing early harmful events that could permanently influence the development of the gut microbiota in childhood. Acta Paediatrica. 2019. 108. 11. 1942-1954.
  2. Giles EM and Couper J. Microbiome in health and disease. Journal of Paediatrics and Child Health. 2020. 56. 11. 1735-1738.
  3. McBurney MI et al, Establishing what constitutes a healthy human gut microbiome: State of the science, regulatory considerations and future directions. Journal of Nutrition. 2019. 149. 1882-1895.
  4. Hoang DM et al, The impact of Caesarean section on the infant gut microbiome. Acta Paediatrica. 2021. 110. 1. 60-67.
  5. Shao Y et al, Stunted microbiota and opportunistic pathogen colonisation in caesarean section birth. Nature Biotechnology. 2019. 37. 2. 186.
  6. Musilova S et al, Colonisation of the gut by bifidobacterial is much more common in vaginal deliveries than Caesarean sections. Acta Paediatrica. 2015. 104. 4. E184-E186.
  7. Betrán AP, et al, The increasing trend in caesarean section rates: Global, regional and national estimates: 1990–2014. PLoS One. 2016. 11(2):e0148343.
  8. Dominguez-Bello MG et al, Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings of the National Academy of Science. USA. 2010. 107. 26. 11971-11975.
  9. Jakobsson HE et al, Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut. 2014. 63.4. 559-566.
  10. Ianiro G et al, Antibiotics as deep modulators of gut microbiota: between good and evil. Gut 2016. 65, 1906–1915.
  11. Vandenplas Y et al, Factors affecting early-Llfe intestinal microbiota development. Nutrition 2020. 78, 110812.
  12. Dierikx TH et al, The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review. Journal of Infection. 2020. 81, 190–204
  13. Panda S.et al Short-term effect of antibiotics on human gut microbiota. PLoS ONE 2014. 9, e95476.
  14. Bervoets L et al,. Differences in Gut Microbiota Composition between Obese and Lean Children: A Cross-Sectional Study. Gut Pathog. 2013. 5. 1–10.
  15. Kasai, C et al. Comparison of the Gut Microbiota Composition between Obese and Non-Obese Individuals in a Japanese Population, as Analyzed by Terminal Restriction Fragment Length Polymorphism and next-Generation Sequencing. BMC Gastroenterol. 2015. 15. 1–10.
  16. Ley, R.E.; et al. Microbes Associated with Obesity. Nature 2006. 444. 1022–1023.
  17. Vatanen T, Franzosa EA, Schwager Ret al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 2018; 562: 589–94.
  18. Stewart CJ, Ajami NJ, O’Brien JLet al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 2018; 562: 583–8.
  19. Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut 2019; 68: 1108–14.